Value-based pricing: who should set drug prices in the UK?
Value-based pricing: who should set drug prices in the UK?
While the UK's NHS and pharma sector ponder who may end up negotiating drug prices in light of a new white paper, health economists Stuart Carroll, Neil Hawkins and David A Scott contemplate four options which keep NICE very much in the picture
28-29
Carroll, S.
8f6e45f0-6873-4050-8d4c-0c23147e8d98
Hawkins, N.
f923582b-d3ac-41e6-9c21-2f4d0d87771d
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
11 August 2010
Carroll, S.
8f6e45f0-6873-4050-8d4c-0c23147e8d98
Hawkins, N.
f923582b-d3ac-41e6-9c21-2f4d0d87771d
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Carroll, S., Hawkins, N. and Scott, David Alexander
(2010)
Value-based pricing: who should set drug prices in the UK?
Scrip, 20 (August), .
Abstract
While the UK's NHS and pharma sector ponder who may end up negotiating drug prices in light of a new white paper, health economists Stuart Carroll, Neil Hawkins and David A Scott contemplate four options which keep NICE very much in the picture
This record has no associated files available for download.
More information
Published date: 11 August 2010
Identifiers
Local EPrints ID: 441394
URI: http://eprints.soton.ac.uk/id/eprint/441394
PURE UUID: fe71b36b-a7dd-4160-ad28-3305cbbd6d61
Catalogue record
Date deposited: 11 Jun 2020 16:30
Last modified: 13 Dec 2021 03:38
Export record
Contributors
Author:
S. Carroll
Author:
N. Hawkins
Author:
David Alexander Scott
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics